Trends in antibiotic resistance over time among pathogens from Canadian hospitals: results of the CANWARD study 2007-11
Open Access
- 14 April 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 68 (suppl 1), i23-i29
- https://doi.org/10.1093/jac/dkt023
Abstract
Antimicrobial resistance patterns change over time and longitudinal surveillance studies provide insight into these trends. We sought to describe the important trends in antimicrobial resistance in key pathogens across Canada to provide useful information to clinicians, policy makers and industry, to assist in optimizing antimicrobial therapy, formulary choices and drug development. We analysed longitudinal data from the CANWARD study using a multivariate regression model to control for possible effects of patient demographics on resistance, in order to assess the impact of time on antimicrobial resistance independent of other measured variables. We identified several key trends in common pathogens. In particular, we observed a statistically significant increase in the proportion of Escherichia coli isolates that were resistant to extended-spectrum cephalosporins and fluoroquinolones, an increase in the proportion of Klebsiella pneumoniae isolates that were resistant to extended-spectrum cephalosporins, a reduction in the proportion of Staphylococcus aureus that were methicillin, clindamycin and trimethoprim/sulfamethoxazole resistant, and a reduction in the proportion of Pseudomonas aeruginosa that were fluoroquinolone and gentamicin resistant. Although some of these trends, such as the dramatic increase in fluoroquinolone and cephalosporin resistance in E. coli, can be attributed to the emergence and global spread of resistant clones (e.g. ST131 E. coli), others remain unexplained. However, recognizing these trends remains important to guide changes in empirical antimicrobial therapy and drug development.Keywords
This publication has 35 references indexed in Scilit:
- Mandatory surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in England: the first 10 yearsJournal of Antimicrobial Chemotherapy, 2012
- Waves of trouble: MRSA strain dynamics and assessment of the impact of infection controlJournal of Antimicrobial Chemotherapy, 2011
- Prevalence and characterization of extended-spectrum β-lactamase– and AmpC β-lactamase–producing Escherichia coli: results of the CANWARD 2007–2009 studyDiagnostic Microbiology and Infectious Disease, 2011
- Antimicrobial susceptibility of 15,644 pathogens from Canadian hospitals: results of the CANWARD 2007–2009 studyDiagnostic Microbiology and Infectious Disease, 2011
- Decline of meticillin-resistant Staphylococcus aureus in Oxfordshire hospitals is strain-specific and preceded infection-control intensificationBMJ Open, 2010
- Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strainJournal of Antimicrobial Chemotherapy, 2010
- Infections with Extended-Spectrum β-Lactamase-Producing EnterobacteriaceaeDrugs, 2010
- Has the era of untreatable infections arrived?Journal of Antimicrobial Chemotherapy, 2009
- Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniaeClinical Microbiology & Infection, 2009
- Development and Persistence of Antimicrobial Resistance in Pseudomonas aeruginosa : a Longitudinal Observation in Mechanically Ventilated PatientsAntimicrobial Agents and Chemotherapy, 2007